Depression severity in electroconvulsive therapy (ECT) versus pharmacotherapy trials

Journal of ECT

Volumn 31, Issue 1, 2015, Pages 31-33

  Kellner, Charles H ^a   Kaicher, David C ^b   Banerjee, Hiya ^c   Knapp, Rebecca G ^c   Shapiro, Rachael J ^d   Briggs, Mimi C ^e   Pasculli, Rosa M ^f   Popeo, Dennis M ^g   Ahle, Gabriella M ^a   Liebman, Lauren S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Crozer Keystone Health System   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NEW YORK UNIVERSITY   (United States)

Author keywords

ECT; electroconvulsive therapy; Hamilton Rating Scale for Depression; major depression; pharmacotherapy

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; DEPRESSION; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; PSYCHOPHARMACOTHERAPY; RATING SCALE; SAMPLE SIZE; SCORING SYSTEM; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMANS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 84924275976     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0000000000000135     Document Type: Article

References (15)

1. American Psychiatric Association. Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association; 2001
2. Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67(suppl 6):16-22
3. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62
4. Abrams R. Electroconvulsive Therapy. 4th ed. New York, NY: Oxford University Press; 2002
5. FDA Executive Summary. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM240933.pdf. 2011. Accessed November 1, 2012
6. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303:47-53
7. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗D: implications for clinical practice. Am J Psychiatry. 2006;163:28-40
8. Shelton RC, Haman KL, Rapaport MH, et al. A randomized, double-blind, active control study of sertraline versus venlafaxine XR in major depressive disorder. J Clin Psychiatry. 2006; 67:1674-1681
9. Bax L, Yu LM, Ikeda N, et al. MIX: comprehensive free software for meta analysis of casual research data-Version 1.54. 2006. Available at: www.mix-for-metaanalysis.info. Accessed June 1, 2012
10. Description of the Hamilton Depression Rating Scale (HAMD) and the Montgomery-Asberg Depression Rating Scale (MADRS). Available at: http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4273b1-04-descriptionofmadrshamddepressionr(1).pdf. 2007. Accessed November 1, 2012
11. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006; 63:1337-1344
12. Kellner CH, Knapp R, Husain MM, et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010; 196:226-234
13. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389
14. Kramer P. In defense of antidepressants. New York Times. July 9, 2011
15. Goodman WK. Electroconvulsive therapy in the spotlight. N Engl J Med. 2011;364:1785-1787.